Drug Name Dosag

Mechanism of Indicatio Client Nursing

and e and Contraindications Side Effects
Action n Response Responsibilities
Classification Route
Generic 30 Insulin initiate Used to  Hypersensitivit  Injection site reactions Patient  Monitor
Name: units s its action by control y (pain, redness, responded patient
Regular SQ binding to a blood  Low blood irritation) well to response to
Human before glycoprotein glucose sugar  Headache medication therapy
Insulin meals receptor on in (hypoglycemia  Influenza-like . (stabilization
the surface of patients ) symptoms of blood
Brand Name: the cell. This who have  Indigestion glucose
Humulin R receptor type 1  Diarrhea levels).
consists of an diabetes  Back pain  Monitor for
Classification alpha-subunit, mellitus.  Sore throat adverse effects
: which binds  Low blood (hypoglycemi
Antidiabetics the hormone, sugar symptoms a,
and a beta- (hypoglycemia) ketoacidosis,
subunit, which including headache, injection-site
is an insulin- hunger, irritation).
stimulated, weakness, sweating,  Evaluate
tyrosine- tremors, irritability, patient
specific trouble concentrating, understanding
protein kinase. rapid breathing, fast on drug
heartbeat, fainting, or therapy by
seizures. asking the
 Insulin resistance patient to
 Body fat redistribution name the
 Abnormal accumulatio drug, its
n of fat underneath the indication, and
surface of the skin adverse effects
 Local allergic reaction to watch for.
 Monitor
patient
compliance to

This study source was downloaded by 100000842455745 from CourseHero.com on 02-24-2022 10:02:24 GMT -06:00
 drug therapy.
 Gently rotate
the vial
containing the
agent and
avoid
vigorous
shaking to
ensure
uniform
suspension of
insulin.
 Rotate
injection
sites to avoid
damage to
muscles and to
prevent
subcutaneous
atrophy.
 Monitor
response
carefully to
avoid adverse
effects.
 Always verify
the name of
the insulin
being
given because
each insulin
has a different
peak and

This study source was downloaded by 100000842455745 from CourseHero.com on 02-24-2022 10:02:24 GMT -06:00
 duration, and
the names can
be confused.
 Provide
patient
education
about drug
effects and
warning signs
to report to
enhance
patient
knowledge
and to
promote
compliance.

This study source was downloaded by 100000842455745 from CourseHero.com on 02-24-2022 10:02:24 GMT -06:00
 Drug Name Dosage
Mechanism of Indicatio Contraindicatio Client
and and Adverse Effects Nursing Responsibilities
Action n ns Response
Classification Route
Generic Name: 10mg/ta It inhibits To Contraindicated  CNS: Dizziness, Patient have
Amlodipine b PO calcium ion control in patients with light- responded  Monitor BP for
OD influx across high known headedness, well to the therapeutic
Brand Name: cell blood sensitivity to headache, asthe medication. effectiveness. BP
Norvasc membranes, pressure amlodipine. nia, fatigue, reduction is greatest
with a lethargy after peak levels of
Classification: greater effect o  CV: Peripheral amlodipine are
Antihypertensi n vascular edema, arrhyth achieved 6–9 h
ve smooth muscle mias following oral doses.
Calcium cells. This  Dermatologic: F
channel causes lushing, rash  Monitor for S&S of
blockers vasodilation  GI: Nausea, abd dose-related
and a reduction ominal peripheral or facial
in peripheral discomfort edema that may not be
vascular accompanied by
resistance, thus weight gain; rarely,
lowering blood severe edema may
pressure. cause discontinuation
of drug.
 Monitor BP with
postural changes.
Report postural
hypotension. Monitor
more frequently when
additional
antihypertensives or
diuretics are added.
 Monitor heart rate;
dose-related
palpitations (more

This study source was downloaded by 100000842455745 from CourseHero.com on 02-24-2022 10:02:24 GMT -06:00
 common in women)
may occur.

 Instruct the patient to

report significant
swelling of face or
extremities.

 Instruct the patient to

report shortness of
breath, palpitations,
irregular heartbeat,
nausea, or
constipation to
physician.

This study source was downloaded by 100000842455745 from CourseHero.com on 02-24-2022 10:02:24 GMT -06:00
Powered by TCPDF (www.tcpdf.org)